Clinical and Biochemical Evaluation of Dental and Periodontal Conditions in Children With Juvenile Idiopathic Arthritis

February 18, 2022 updated by: Marmara University
Aimed to be done in the planned thesis to evaluate the dental and periodontal health of patients with newly diagnosed JIA and healthy-periodontal problems with cytokines from saliva and oxidative stress markers non-invasively, and thus, to determine the markers' evaluability in terms of markers in determining the state of inflammation among individuals with and without the disease.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

Periodontal diseases and inflammatory diseases such as arthritis show similar clinical pathologies such as connective tissue deterioration and bone destruction. They carry the risk of being seen together and the possibility of mutual influence. It is important whether these patients have a difference in cytokine profile from individuals who do not have the disease. In the literature, it has been determined that pro and anti-inflammatory cytokines, which are involved in the pathogenesis of periodontitis, are also involved in the pathogenesis of juvenile idiopathic arthritis (JIA). Cytokines play an undeniable role in the pathogenesis of both diseases. The cytokine profile in periodontal disease is distinctly similar to that of rheumatoid arthritis (RA). As in RA, the level of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) increase in periodontal disease. Again, it is stated that oxidative stress assessment is an important factor in evaluating the development of the disease. Saliva evaluation can be made with new oxidative stress markers that can be used in this sense.

On the subject of the proposed thesis; It is to determine the profile of dental and periodontal health in a specific group in terms of biochemical and microbiology using different body fluids together with clinical findings and has an interdisciplinary character. Aimed to be done in the planned thesis;

It was aimed to evaluate the dental and periodontal health of patients with newly diagnosed JIA and healthy-periodontal problems with cytokines from saliva and oxidative stress markers non-invasively, and thus, to determine the markers' evaluability in terms of markers in determining the state of inflammation among individuals with and without the disease.

Study Type

Observational

Enrollment (Anticipated)

114

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maltepe
      • Istanbul, Maltepe, Turkey
        • Marmara University Faculty of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 16 years (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients who have no disease other than juvenile idiopathic arthritis, newly diagnosed and not yet using medication.

Description

Inclusion Criteria:

  • healty patients

Exclusion Criteria:

  • used antibiotics within the last 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patient with juvenile idiopathic arthritis and gingivitis
It is a group of patients between the ages of 5 and 16 who have recently been diagnosed with juvenile idiopathic arthritis and gingivitis, have not used medication yet.

ELISA (enzyme-linked immunosorbent assay) is a plate-based assay technique designed for detecting and quantifying soluble substances such as peptides, proteins, antibodies, and hormones.

The saliva of the patients included in the study will be examined with ELISA kits after they are taken.

healthy patient group with gingivitis
It is a group of healthy patients with gingivitis between the ages of 5-16 who have not taken antibiotics in the last 3 months.

ELISA (enzyme-linked immunosorbent assay) is a plate-based assay technique designed for detecting and quantifying soluble substances such as peptides, proteins, antibodies, and hormones.

The saliva of the patients included in the study will be examined with ELISA kits after they are taken.

healthy patient group without gingivitis
It is a group of healthy patients without gingivitis between the ages of 5-16 who have not taken antibiotics in the last 3 months.

ELISA (enzyme-linked immunosorbent assay) is a plate-based assay technique designed for detecting and quantifying soluble substances such as peptides, proteins, antibodies, and hormones.

The saliva of the patients included in the study will be examined with ELISA kits after they are taken.

patient with juvenile idiopathic arthritis and without gingivitis
It is a group of patients between the ages of 5 and 16 who have recently been diagnosed with juvenile idiopathic arthritis and without gingivitis, have not used medication yet.

ELISA (enzyme-linked immunosorbent assay) is a plate-based assay technique designed for detecting and quantifying soluble substances such as peptides, proteins, antibodies, and hormones.

The saliva of the patients included in the study will be examined with ELISA kits after they are taken.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
biochemical evaluation of saliva in juvenile idiopathic arthritis
Time Frame: baseline
Saliva samples were taken from the patients and the levels of interleukin-17, TNF alpha and Total antioxidant status in the saliva were measured with ELISA kits.
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of oral hygiene in patients with juvenile idiopathic arthritis
Time Frame: baseline
The number of caries in the patient was evaluated with the DMFT-dft index.
baseline
Evaluation of periodontal health in patients with juvenile idiopathic arthritis
Time Frame: baseline
Silness-Loe plaque index (PI) was used to assess periodontal health.
baseline
Examination of periodontal health in patients with juvenile idiopathic arthritis
Time Frame: baseline
Gingival index (GI) was also used to examination periodontal health.
baseline
periodontal health in patients with juvenile idiopathic arthritis
Time Frame: baseline
Bleeding on prob index were used for periodontal health examination.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Betul Sozeri, Researcher
  • Study Chair: Ferhat Demir, Researcher
  • Study Chair: Selin Yıldırım, Researcher

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 6, 2020

Primary Completion (ANTICIPATED)

May 15, 2022

Study Completion (ANTICIPATED)

September 1, 2022

Study Registration Dates

First Submitted

January 21, 2022

First Submitted That Met QC Criteria

January 30, 2022

First Posted (ACTUAL)

February 1, 2022

Study Record Updates

Last Update Posted (ACTUAL)

February 21, 2022

Last Update Submitted That Met QC Criteria

February 18, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gingivitis

Clinical Trials on Humans ELISA kits

Subscribe